Golden opportunity to get residential plot at Mandola Vihar scheme of U.P. Housing Development Council

Share this post

Uttar Pradesh Housing Development Council is developing Mandola Vihar scheme near Trans Delhi Signature City (formerly known as Tronica City). In this project of about 2800 acres, most of the area is being developed as residential along with group housing, commercial, school and other facilities are also being provided.

The above project was pending for a long time in which around 20 to 25000 flats have already been allotted. Now the Housing Development Council is going to allot 546 residential plots of 200.00, 112.50, 75.00 and 40.74 square meter.

The reservation rate of allotment has been fixed at Rs 26880 per meter which also includes freehold charge. Since the project is freehold, it will be a very profitable deal in the future. Also, due to development along with Tronica City, the rates of residential areas of both townships will also increase. Online registration for applying plots has been start from 15 December 2023 and will continue till 15 January 2024.

The special attractions of Mandola Vihar Project are as follows:

The project is spread on both sides of Delhi Saharanpur National Highway 709B.

Entry and exit from Akshardham to Dehradun Economic Corridor specifically for this project.

Distance from interstate bus turminal 15 kilometers

Distance from Shiv Vihar Metro Station 9 kilometers

8 kilometers from Eastern Peripheral Expressway crossing

Just 4 kilometers from Delhi border

For detailed information please go through the registration booklet enclosed herewith.

Join our group for more news in future

1 comment

Mange Ram January 23, 2024 Reply

Mandola vihar sector 23 ka plotting lucky draw kb hona h

Leave a Reply

Your email address will not be published. Required fields are marked *


Related stories

उत्तर प्रदेश सरकार ने औद्योगिक भूमि आवंटन के लिए 25,000 एकड़ भूमि का अधिग्रहण किया

Golden chance to get Industrial plot in direct allotment scheme at various sites of UPSIDA